CapitalNumbers Infotech SME IPO allotment on January 23; Here’s how you can check status online, NSE, Bigshare

CapitalNumbers Infotech IPO, an SME issue, opened for subscription from January 20 to January 22. The issue is likely to finalise the allotment of the shares today, January 23, after its completion of the two-day bidding.

Individuals who took part in the IPO can check the allotment status online via platforms like NSE and the registrar of the issue, Bigshare Services.

Here’s how to check the allotment status – Via NSE

Step 1 

Visit the NSE website.

Step 2

Go to the “Application Status” page and choose the option “Equity and SME IPO bid details.”

Step 3

Now, select ‘EMA Partners India Ltd’ from the dropdown list of companies.

Step 4

Enter your IPO application number or PAN details.

Step 5

Click the “Submit” button to view the allotment details.

– Via Link Intime India

Step 1

Go to the website of the registrar CapitalNumbers Infotech and navigate to the public issues. Link Intime India is working as the registrar. 

Step 2

You need to fill in all your details such as the company’s name and PAN card number

Step 3

You’re all set to go. Just hit the search button to check the allotment status.

CapitalNumbers Infotech GMP

The SME company’s shares were fetching a premium of 24% in the grey market. This indicates that the stock might list at a price of around Rs 326 on the BSE SME platform. The grey market is an unofficial place to trade shares ahead of listing. Market participants track GMP to track listing gains.

CapitalNumbers Infotech IPO details

The company aims to raise a sum of around Rs 170 crore from the primary markets. The issue was a combination of fresh shares as well as the sale of promoter shares. The shares of the company are likely to be listed on the BSE SME platform on January 27. It fixed the price band of the issue around Rs 250 to Rs 263 per equity share. GYR Capital Advisors is the sole book-running lead manager of the SME IPO, while Link Intime India is the registrar for the issue. The market maker is Giriraj Stock Broking.

 » Read More

Related Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

8th Pay Commission: Central govt to merge pay scales for Level 1-6 employees? Here’s what the new proposal says

8th Pay Commission: The National Council of Joint Consultative Machinery (JCM) Staff Side has submitted its recommendations for the Terms of Reference (ToR) for the 8th Central Pay Commission (CPC), advocating significant changes in pay structure, allowances and benefits for government employees. Among the key points of ToR is the proposal for merger of certain

Bharti Airtel Q3 Results: Profit surges 505.24% to Rs 14,781.20 crore, ARPU at Rs 245

Bharti Airtel on Thursday posted a profit of Rs 14,781.20 crore during the third quarter of FY25, reporting a growth of 505.24 per cent in comparison to Rs 2442.20 crore during the corresponding quarter of FY24. The telecom major recorded Q3 revenue from operations at Rs 45,129.30 crore, up 19.08 per cent as against Rs

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain